{"id":859,"date":"2020-01-22T13:37:01","date_gmt":"2020-01-22T13:37:01","guid":{"rendered":"https:\/\/www.bioevents.net\/leukemia2020\/?page_id=859"},"modified":"2020-01-22T13:37:21","modified_gmt":"2020-01-22T13:37:21","slug":"abstract-topics","status":"publish","type":"page","link":"https:\/\/euroleuk.com\/abstract-topics\/","title":{"rendered":"Abstract Topics"},"content":{"rendered":"
Biology of ALL, AML, CML, CLL Leukemia stem cells (LSCs) Routing diagnosis gene expression and mutational profiling Allogeneic hematopoietic stem cell transplantation Front-line treatment of ALL, AML, CML, CLL Treatment of resistant\/relapsed disease How novel agents are changing the treatment landscape of ALL, AML, CML and CLL Immunotherapy Minimal residual disease Clinical Cases (Case) Reports<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-859","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\n